Influencing factors and clinical significance of hypoviremia in HIV

LV Haiwei,LIU Li,CHEN Ju,HU Jingjing,LU Hongzhou
DOI: https://doi.org/10.3969/j.issn.1002-1310.2022.05.001
2022-01-01
Abstract:Objective To understand the influencing factors of low-level HIV viremia(LLV) and its impact on virological failure(VF). Methods Demographic characteristics and clinical data were retrospectively collected from HIV-infected patients who started ART from January 1,2011,to December 31,2015,and followed up to December 31,2020,and aged 18 or more. The subjects were divided into long-term inhibition group and LLV group. The age,sex,baseline viral load,baseline CD 4 + T-lymphocyte count,adherence,and whether to change medication during follow-up were compared and analyzed between the suppression and LLV groups. Results A total of 3787 patients with a median age of 34(27,46) years and 92.81% male were included in this study,of which 3201(84.53%) were in the suppression group.Among them,age,baseline VL ≥ 1×105 copies/mL,poor compliance,baseline CD 4 + T lymphocyte count ≥ 200cells/mm~3,core drugs in the initial ART regimen and presence of comorbidities may be the influencing factors of LLV.59.73% of patients in the LLV group developed LLV within 1 year after starting ART.LLV was a risk factor for VF when LLV patients had a VL ≥ 200copies/ml. Conclusion When factors affecting LLV are present in HIV-infected patients on ART or when VL in LLV patients is ≥ 200copies/ml,clinicians need to pay high attention to the changes in VL in patients during this period and increase the frequency of VL testing in patients if necessary.
What problem does this paper attempt to address?